Corporate Banner
Satellite Banner
Technology Networks Header
Monday, November 24, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Ultra Low Temperature Rack for Tissue Storage Tubes
Monday, November 24, 2014
Micronic launch new new ultra-low temperature rack for tissue tube storage.

Organovo Announces Commercial Release of the exVive3D™ Human Liver Tissue
Friday, November 21, 2014
exVive3D™ human liver tissue for preclinical drug discovery testing.

Optimizing Workflow with 96- & 384-well Microplates
Thursday, November 20, 2014
INTEGRA has introduced a Three Position Stage for its VIAFLO 96 and VIAFLO 384 handheld benchtop pipettes.

Affordable, Reliable Quality Imaging with the SC50 Camera
Wednesday, November 19, 2014
High quality digital microscopy is now more accessible than ever with the new 5 Megapixel SC50 microscope camera from Olympus, bringing fast, Full HD live imaging and more to a host of routine applications.

Porvair Launches Electronic Mat Capper
Wednesday, November 19, 2014
E-capper minimises the risk of RSI in operators.

Artel Further Enhances ArtelWare™ Software
Friday, November 14, 2014
Company’s ArtelWare v1.2 software to provide liquid handler performance trending.

Fluorescence-based Mitochondria / Metabolism Assays
Friday, November 14, 2014
Strategic marketing agreement with Luxcel to distribute 96- and 384-well phosphorescence and fluorescence based assays.

Olympus DSX100 Opto-Digital System
Thursday, November 13, 2014
Offers biological imaging with smartphone ease.

Nagoya University’s ITbM, Japan, Licenses Cresset’s Forge
Thursday, October 30, 2014
ITbM licenses Cresset’s computational chemistry software to accelerate their research.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 2602
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv